Jci_page_head_homepage_01 Jci_page_head_homepage_02
Manu V. Chakravarthy, Yimin Zhu, Miguel López, Li Yin, David F. Wozniak, Trey Coleman, Zhiyuan Hu, Michael Wolfgang, Antonio Vidal-Puig, M. Daniel Lane, Clay F. Semenkovich
Published in Volume 117, Issue 9
J Clin Invest. 2007; 117(9):2539–2552 doi:10.1172/JCI31183
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 9
Bilateral stereotaxic injection of PPARα agonist into the ventral hypothalamus restores PPARα signaling and normalizes food intake in FASKO mice.

(A) Wy14,643 (10 μg in 20% dimethyl sulfoxide and 0.05% Evans blue dye in artificial cerebrospinal fluid) was delivered into the ventral hypothalamus by bilateral stereotaxic injection. Twenty-four hours later, the brain was sectioned and examined for the presence of Evans blue dye. Shown is the typical pattern observed in the ventral hypothalamus with a prominent presence of dye in the region of the arcuate nucleus and ventromedial hypothalamus. Original magnification, ×2.5. (B and C) Effect of a single intrahypothalamic injection of vehicle (20% dimethyl sulfoxide and 0.05% Evans blue dye in artificial cerebrospinal fluid) and Wy14,643 (10 μg) on food intake (upper panels) and body weight change (lower panels) in freely feeding WT and FASKO mice. (D) Effect of intrahypothalamic injection of vehicle and Wy14,643 on mRNA levels of PPARα and its target genes (ACO, CPT-1, and MCD) in the hypothalamus by quantitative RT-PCR at the end of the 24-hour feeding period. All results represent mean ± SEM for n = 5 per genotype for vehicle and n = 7 per genotype for Wy groups. *P < 0.05 compared with corresponding WT; #P < 0.05 compared with corresponding vehicle-treated animals; **P < 0.05 compared with vehicle-treated FASKO mice.